These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 29369775)

  • 1. Intestinal IFN-γ-producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease.
    Alfen JS; Larghi P; Facciotti F; Gagliani N; Bosotti R; Paroni M; Maglie S; Gruarin P; Vasco CM; Ranzani V; Frusteri C; Iseppon A; Moro M; Crosti MC; Gatti S; Pagani M; Caprioli F; Abrignani S; Flavell RA; Geginat J
    J Allergy Clin Immunol; 2018 Nov; 142(5):1537-1547.e8. PubMed ID: 29369775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
    Cook L; Stahl M; Han X; Nazli A; MacDonald KN; Wong MQ; Tsai K; Dizzell S; Jacobson K; Bressler B; Kaushic C; Vallance BA; Steiner TS; Levings MK
    Gastroenterology; 2019 Dec; 157(6):1584-1598. PubMed ID: 31513797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.
    Globig AM; Hennecke N; Martin B; Seidl M; Ruf G; Hasselblatt P; Thimme R; Bengsch B
    Inflamm Bowel Dis; 2014 Dec; 20(12):2321-9. PubMed ID: 25248005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tripartite motif-containing (TRIM) 21 negatively regulates intestinal mucosal inflammation through inhibiting T
    Zhou G; Wu W; Yu L; Yu T; Yang W; Wang P; Zhang X; Cong Y; Liu Z
    J Allergy Clin Immunol; 2018 Oct; 142(4):1218-1228.e12. PubMed ID: 29113905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases.
    Hovhannisyan Z; Treatman J; Littman DR; Mayer L
    Gastroenterology; 2011 Mar; 140(3):957-65. PubMed ID: 21147109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis.
    Yu QT; Saruta M; Avanesyan A; Fleshner PR; Banham AH; Papadakis KA
    Inflamm Bowel Dis; 2007 Feb; 13(2):191-9. PubMed ID: 17206665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells.
    Makita S; Kanai T; Oshima S; Uraushihara K; Totsuka T; Sawada T; Nakamura T; Koganei K; Fukushima T; Watanabe M
    J Immunol; 2004 Sep; 173(5):3119-30. PubMed ID: 15322172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency.
    Kutukculer N; Azarsiz E; Aksu G; Karaca NE
    Int J Immunopathol Pharmacol; 2016 Jun; 29(2):241-51. PubMed ID: 26684629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of novel CD8
    Fan JN; Ho H; Chiang BL
    Cell Mol Life Sci; 2024 Aug; 81(1):327. PubMed ID: 39085655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-18Rα-deficient CD4(+) T cells induce intestinal inflammation in the CD45RB(hi) transfer model of colitis despite impaired innate responsiveness.
    Holmkvist P; Pool L; Hägerbrand K; Agace WW; Rivollier A
    Eur J Immunol; 2016 Jun; 46(6):1371-82. PubMed ID: 27062602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamina Propria CD4+LAP+ Regulatory T Cells Are Increased in Active Ulcerative Colitis but Show Increased IL-17 Expression and Reduced Suppressor Activity.
    D'Ambrosio A; Cossu A; Amendola A; Zandri A; Butera A; Sanchez M; Biffoni M; Pronio A; Montesani C; Kohn A; Pica R; Boirivant M
    J Crohns Colitis; 2016 Mar; 10(3):346-53. PubMed ID: 26589955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eomesodermin controls a unique differentiation program in human IL-10 and IFN-γ coproducing regulatory T cells.
    Gruarin P; Maglie S; De Simone M; Häringer B; Vasco C; Ranzani V; Bosotti R; Noddings JS; Larghi P; Facciotti F; Sarnicola ML; Martinovic M; Crosti M; Moro M; Rossi RL; Bernardo ME; Caprioli F; Locatelli F; Rossetti G; Abrignani S; Pagani M; Geginat J
    Eur J Immunol; 2019 Jan; 49(1):96-111. PubMed ID: 30431161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A B-1a cell subset induces Foxp3(-) T cells with regulatory activity through an IL-10-independent pathway.
    Hsu LH; Li KP; Chu KH; Chiang BL
    Cell Mol Immunol; 2015 May; 12(3):354-65. PubMed ID: 25132452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases.
    Sarra M; Monteleone I; Stolfi C; Fantini MC; Sileri P; Sica G; Tersigni R; Macdonald TT; Pallone F; Monteleone G
    Inflamm Bowel Dis; 2010 Aug; 16(8):1332-9. PubMed ID: 20186935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An endogenous aryl hydrocarbon receptor ligand, ITE, induces regulatory T cells and ameliorates experimental colitis.
    Abron JD; Singh NP; Mishra MK; Price RL; Nagarkatti M; Nagarkatti PS; Singh UP
    Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G220-G230. PubMed ID: 29672155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.
    Bisping G; Lügering N; Lütke-Brintrup S; Pauels HG; Schürmann G; Domschke W; Kucharzik T
    Clin Exp Immunol; 2001 Jan; 123(1):15-22. PubMed ID: 11167992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.
    Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y
    Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activated CD4+ T cells from interferon-gamma (IFN-gamma)-deficient mice induce intestinal inflammation in immunodeficient hosts.
    Bregenholt S; Brimnes J; Nissen MH; Claesson MH
    Clin Exp Immunol; 1999 Nov; 118(2):228-34. PubMed ID: 10540183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CCR6 and CXCR6 by Gut-Derived CD4
    Godefroy E; Alameddine J; Montassier E; Mathé J; Desfrançois-Noël J; Marec N; Bossard C; Jarry A; Bridonneau C; Le Roy A; Sarrabayrouse G; Kerdreux E; Bourreille A; Sokol H; Jotereau F; Altare F
    Gastroenterology; 2018 Oct; 155(4):1205-1217. PubMed ID: 29981781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B7H1-Ig fusion protein activates the CD4+ IFN-gamma receptor+ type 1 T regulatory subset through IFN-gamma-secreting Th1 cells.
    Ding Q; Lu L; Wang B; Zhou Y; Jiang Y; Zhou X; Xin L; Jiao Z; Chou KY
    J Immunol; 2006 Sep; 177(6):3606-14. PubMed ID: 16951320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.